Categories Technology

AT&T’s subsidiary Vrio files for IPO

Vrio Corp, the DirectTV business of AT&T (T) based in Latin America, which confidentially filed for an IPO early this year, said it expects to raise about $653 million through the process.

Courtesy – Wikimedia Commons

Based on the latest amended form filed by Vrio, it is said that the firm expects to value its 29.68 million shares of Class A common stock in the range of about $19 to $22 per share. The company has also highlighted the possibility of an additional allotment of 4.45 million shares. Vrio plans to publicly trade its share on NYSE under the ticker VRIO.

AT&T, which is currently battling it out with the U.S. Department of Justice over its proposed $85 billion purchase of Time Warner (TWX), initially planned to unload this Texas-based unit – that includes satellite and cable TV services – in order to pay down its debt which would soar after it seals the deal with Time Warner.

Vrio– that offers services to Colombia, Brazil, and Argentina — sees a huge potential in Latin America mostly due to the improved economic conditions as well as the regulatory environment. In fact, the company has had a strong financial performance but has a distance to travel to prove its mettle as a separate entity – especially in the current competitive market.

Founded in 1996, Vrio was acquired by AT&T in 2015 as part of its acquisition of DirectTV. Currently, AT&T stands as a sole shareholder of the company that is headed by Jeffery McElfresh. Vrio’s satellite pay-TV network offers services to about 7.9 million Americans. At the end of 2017, Vrio’s subscriber rate surged 9.3 %.  Even after Vrio’s IPO, AT&T would retain its major voting control over the unit.

As of December 31, 2017, Vrio reported revenue growth of over 11% to $5.57 billion. The company had a total of $443 million in cash. DirectTV Latin America reported 10.9% growth in its revenue last year to $5.57 billion.

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top